Expression of the recombinant tumor necrosis factor binding protein i (tbp-i)
CA 2032191 C · Owner: Brakebusch, Cord · Inventors: Brakebusch, Cord; Wallach, David; Nophar, Yaron
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Tumor Necrosis Factor Binding Protein I (TBP-I) precursors and analogs thereof, are produced by transfecting eukaryotic cells with an expression vector comprising a DNA molecule encoding the whole human type I TNF receptor or a soluble domain thereof, and culturing the transfected cells whereby, the soluble proteins are secreted into the medium.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 13, 1990 and granted May 18, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 13, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 13, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.